APA (7th ed.) Citation

Hirschinger, H., Jaeger, E., Nittka, S., Hetjens, S., Lorenz, C., Remi, C., . . . Boch, T. (2024). Treatment of agitation in terminally ill patients with intranasal midazolam versus subcutaneous midazolam: Study protocol for a randomised controlled open-label monocentric trial (MinTU Study). BMC Palliative Care, 23(1), 1. https://doi.org/10.1186/s12904-023-01330-1

Chicago Style (17th ed.) Citation

Hirschinger, Hanna, et al. "Treatment of Agitation in Terminally Ill Patients with Intranasal Midazolam Versus Subcutaneous Midazolam: Study Protocol for a Randomised Controlled Open-label Monocentric Trial (MinTU Study)." BMC Palliative Care 23, no. 1 (2024): 1. https://doi.org/10.1186/s12904-023-01330-1.

MLA (9th ed.) Citation

Hirschinger, Hanna, et al. "Treatment of Agitation in Terminally Ill Patients with Intranasal Midazolam Versus Subcutaneous Midazolam: Study Protocol for a Randomised Controlled Open-label Monocentric Trial (MinTU Study)." BMC Palliative Care, vol. 23, no. 1, 2024, p. 1, https://doi.org/10.1186/s12904-023-01330-1.